Atorvastatin reduces NF-κB activation and chemokine expression in vascular smooth muscle cells and mononuclear cells

Atherosclerosis

Volumn 147, Issue 2, 1999, Pages 253-261

  Ortego, Mónica ^a   Bustos, Carmen ^a   Hernández Presa, Miguel A ^a   Tuñón, José ^a   Díaz, Cristina ^b   Hernández, Gonzalo ^b   Egido, Jesús ^a  

^a UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

^b Parke Davis SA   (Spain)

Author keywords

Atherosclerosis; Chemokines; Inflammation; NF B; Statins; Vascular smooth muscle cells

Indexed keywords

ANGIOTENSIN; ATORVASTATIN; CHEMOKINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON INDUCING AGENT; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ARTICLE; ATHEROSCLEROTIC PLAQUE; DRUG EFFECT; INFLAMMATION; ISOPRENYLATION; MONONUCLEAR CELL; NONHUMAN; NORTHERN BLOTTING; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; VASCULAR SMOOTH MUSCLE; WESTERN BLOTTING;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; CELLS, CULTURED; CHEMOKINES; CORONARY ARTERIOSCLEROSIS; CORONARY VESSELS; GENE EXPRESSION; HEPTANOIC ACIDS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; MOLECULAR SEQUENCE DATA; MONOCYTES; MUSCLE, SMOOTH, VASCULAR; NF-KAPPA B; POLYMERASE CHAIN REACTION; PYRROLES; RATS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 0032757209     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(99)00193-8     Document Type: Article

References (48)

1. Barnes P., Karin M. Nuclear factor-κB. A pivotal transcription factor in chronic inflammatory diseases. New Engl J Med. 336:1997;1066-1071.
2. Sen R., Baltimore D. Inductibility of κ immunoglobulin enhancer binding protein NF-κB by a posttranslational mechanism. Cell. 47:1986;921-928.
3. Didonato J., Mercurio F., Rosette C. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol Cell Biol. 16:1996;1295-1304.
4. Chen Z.J., Parent L., Maniatis T. Site-specific phosphorylation of IκB by a novel ubiquitination-dependent protein kinase activity. Cell. 84:1996;853-862.
5. Liao F., Andalibi A., deBeer F.C., Fogelman A.M., Lusis A.J. Genetic control of inflammatory gene induction and NF-κB-like transcription factor activation in response to atherogenic diet in mice. J Clin Invest. 91:1993;2572-2579.
6. Hernández-Presa M., Bustos C., Ortego M., Tuñón J., Renedo G., Ruiz-Ortega M. et al. Angiotensin converting enzyme inhibition prevents arterial NF-κB activation, MCP-1 expression and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation. 95:1997;1532-1541.
7. Bourcier T., Sukhova G., Libby P. The nuclear factor κB signaling pathway participates in dysregulation of vascular smooth muscle cells in vitro and in human atherosclerosis. J Biol Chem. 272:1997;15817-15824.
8. Ueda A., Okuda K., Ohno S., Shirai Am Igarashi T., Matsunaga K., Fukushima J. et al. NF-κB and SP1 regulate transcription of the human monocyte chemoattractant protein 1 gene. J Immunol. 153:1994;2052-2063.
9. Ferran C., Millan M.T., Csizmadia V., Cooper J.T., Brostjan C.M., Bach F.H. et al. Inhibition of NF-κB by pyrolidinedithiocarbamate blocks endothelial cell activation. Biochem Biophys Res Commun. 214:1995;212-223.
10. Ohomori Y., Hamilton T.A. The interferon-stimulated response element and kappa B site mediate synergistic induction of murine IP-10 gene transcription by IFN-γ and TNF-α J Immunol. 154:1995;5235-5244.
11. Rollins B.J., Yoshimura T., Leonard E.J., Pover J.S. Cytokine-activated human endothelial cells synthesize and secrete a monocyte chemoattractant, MCP-1/JE. Am J Pathol. 136:1990;1229-1233.
12. Porreca E., Di Febbo C., Reale M., Castellani M.L., Baccante G., Barbacane R. et al. Monocyte chemotactic protein 1 (MCP-1) is a mitogen for cultured rat vascular smooth muscle cells. J Vasc Res. 34:1997;58-65.
13. Taubman M.B., Rollins B.J., Poon M., Marmur J., Green R.S., Berk B.C. et al. JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res. 70:1992;314-325.
14. Taub D.D., Lloyd A.R., Conlon K., Wang J.M., Ortalo J.R., Harada A. et al. Recombinant human interferon-inducible protein 10 is a chemoattractant for human monocytes and promotes T adhesion to endothelial cells. J Exp Med. 177:1993;1809-1814.
15. Wang X., Yue T.L., Ohlstein E.H., Sung C.P., Feuerstein G.Z. Interferon-inducible protein 10 involves vascular smooth muscle cell migration, proliferation, and inflammatory response. J Biol Chem. 271:1996;24286-24294.
16. Brown B.G., Fuster V. Impact of management in stabilization of coronary disease. Fuster V., Ross R., Topol E.J. Atherosclerosis and Coronary Artery Disease. 1996;191-205 Lippincott-Raven, Philadelphia.
17. Brown G., Albers J.J., Fisher L.D., Schefer S.M., Lin J.T., Kaplan C. et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. New Engl J Med. 323:1990;1289-1298.
18. Soma M.R., Donetti E., Parolini C., Mazzini G., Ferrari C., Fumagalli R. et al. HMG-CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arterioscler Thromb. 13:1993;571-578.
19. Hidaka Y., Eda T., Yonemoto M., Kamei T. Inhibition of cultured vascular smooth muscle cell migration by simvastatin (MK-733). Atherosclerosis. 95:1992;87-94.
20. Munro E., Patel M., Chan P., Betteridge L., Clunn G., Gallagher K. et al. Inhibition of human vascular smooth muscle cell proliferation by lovastatin: the role of isoprenoid intermediates of cholesterol synthesis. Eur J Clin Invest. 24:1994;766-772.
21. Kishikawa H., Shimokama T., Watanabe T. Localization of T lymphocytes and macrophages expressing IL-1, IL-2 receptor, IL-6 and TNF-α in human aortic intima. Role of cell mediated immunity in human atherogenesis. Virchows Arch A Pathol Anat. 423:1993;433-442.
22. Rakugi H., Kim D.K., Kriger J.E., Wang D.S., Dzau V.J., Pratt R.E. Induction of angiotensin converting enzyme in the neointima after vascular injury. Possible role in restenosis. J Clin Invest. 93:1994;339-346.
23. Chomczsky P., Sacchy N. Single-step of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 162:1987;156-159.
24. Rollins B.J., Morrison E.D., Stiles C.D. Cloning and expression of JE, a gene inducible by platelet-derived growth factor and whose product has cytokine-like properties. Proc Natl Acad Sci USA. 85:1988;3738-3742.
25. Ohmori Y., Hamilton T.A. A macrophage LPS-inducible early gene encodes the murine homologue of IP-10. Biochem Biophys Res Commun. 168:1990;1261-1267.
26. Luster A.D., Ravetch J.V. Genomic characterization of a gamma-interferon-inducible gene (IP-10) and identification of an interferon-inducible hypersensitive site. Mol Cell Biol. 7:1987;3723-3731.
27. Fort P., Marty L., Piezchaczyk M., Sabrouty S.E., Dani C., Jeanteur P. et al. Various rat adult tissues express only major mRNA species from glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acid Res. 13:1985;1431-1442.
28. Bardy N., Merval R., Benessiano J., Samuel J.L., Tedgi A. Pressure and angiotensin II synergistically induce aortic fibronectin expression in organ culture model of rabbit aorta. Evidence for a pressure-induced tissue renin-angiotensin system. Circ Res. 79:1996;70-78.
29. Schmitz M.L., Bauerle P.A. The p65 subunit is responsible for the strong transcription activating potential of NF-κB. EMBO J. 12:1991;3805-3817.
30. Lindner V., Collins T. Expression of NF-κB and IκBα by aortic endothelium in an arterial injury model. Am J Pathol. 148:1996;427-438.
31. Mené P., Fais S., Cinotti G.A., Pugliese F., Luttmann W., Thierauch K.H. Regulation of U937 monocyte adhesion to cultured human mesangial cells by cytokines and vasoactive agents. Nephrol Dial Transplant. 10:1995;481-489.
32. Morishita R., Gibbons G.H., Nakajima M., Zhang L., Kaneda Y., Ogihara T. et al. Novel and effective gene transfer technique for the study of vascular renin angiotensin system. J Clin Invest. 94:1994;978-984.
33. Schreck R., Rieber P., Bauerle P.A. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kB transcription factor and HIV-1. EMBO J. 10:1991;2247-2258.
34. Bellas R.E., Lee J.S., Sonenshein G.E. Expression of a constitutive NF-κB-like activity is essential for proliferation of cultured bovine vascular smooth muscle cells. J Clin Invest. 96:1995;2521-2527.
35. Bauerle P.A., Henkel T. Function and activation of NF-κ B in the immune system. Annu Rev Immunol. 12:1995;141-179.
36. Ritchie M. Nuclear factor-κB is selectively and markedly activated in humans with unstable angina pectoris. Circulation. 98:1998;1707-1713.
37. Ferns G.A.A., Forster L., Lee A.S., Konneh M., Zadeh J.N., Anggard E.E. Probucol inhibits neointimal thickening and macrophage accumulation after balloon injury in the cholesterol-fed rabbit. Proc Natl Acad Sci USA. 89:1992;11312-11316.
38. Bustos C., Hernández-Presa M.A., Ortego M., Tuñón J., Ortega L., Pérez F. et al. HMG-CoA reductase inhibition by atorvastatin reduces neointimal inflammation in a rabbit model of atherosclerosis. J Am Coll Cardiol. 32:1998;2057-2064.
39. Guijarro C., Kim Y., Schoonover C.M., Massy Z.A., O'Donell M.P., Kasiske B.L. et al. Lovastatin inhibits lipopolysaccharide-induced NF-κB activation in human mesangial cells. Nephrol Dial Transplant. 11:1996;990-996.
40. Goldstein J.L., Brown M.S. Regulation of the mevalonate pathway. Nature. 343:1991;425-430.
41. Repko E.M., Maltese W.A. Post-translational isoprenylation of cellular proteins is altered in response to mevalonate availability. J Biol Chem. 264:1989;9945-9952.
42. Gibbs J.B., Oliff A., Kohl N.E. Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell. 77:1994;175-178.
43. Finco T.S., Baldwin A.S. kB site-dependent induction of gene expression by diverse inducers of nuclear factor kB requires Raf-1. J Biol Chem. 268:1993;17676-17679.
44. Nègre-Aminou P., van Vliet A., van Erck M., van Thiel C.F., van Leeuwen R., Cohen L.H. Inhibition of proliferation of human smooth muscle cells by various HMG-CoA reductase inhibitors; comparison with other human cell types. Biochim Biophys Acta. 1345:1997;259-268.
45. O′Donell M., Kaseske B.L., Kim Y., Atluru D., Keane W. Lovastatin inhibits proliferation of rat mesangial cells. J Clin Invest. 91:1993;83-87.
46. Reedquist K., Pope T.K., Roess D.A. Lovastatin inhibits proliferation and differentiation and causes apoptosis in lipopolysaccharide-stimulated murine B cells. Biochem Biophys Res Commun. 211:1995;665-670.
47. Bretschneider E., Wittpoth M., Weber A.A., Glusa E., Schoror K. Activation of NFkappaB is essential but not sufficient to stimulate mitogenesis of vascular smooth muscle cells. Biochem Biophys Res Commun. 235:1997;365-368.
48. Wang J.M., Peri G., Walter S., Padura I.M., Libby P., Ceska M. et al. Expression of monocyte chemotactic protein and interleukin-8 by cytokine activated human vascular smooth muscle cells. Arterioscler Thromb. 11:1991;1166-1174.